Share this
Cooley Advises on Follow-On Offerings for Reata + argenx
December 5, 2019
Guild Education Closes $157 Million Series D
December 2, 2019
Best Lawyers 2020 – Cooley
November 18, 2019
Fangdd – $78 Million IPO
November 6, 2019
Manchester Financial Closes $425 Million Refinance of Fairmont Austin Hotel
October 22, 2019
Datadog – $745.2 Million IPO
October 1, 2019
Zoom Video Communications – $864 Million IPO
June 11, 2019
Chambers USA 2019 Recognizes Cooley Lawyers + Practices
April 30, 2019
Cooley M&A Insight From Q4 2018
January 24, 2019
Taiwan Liposome Company Completes US IPO
January 3, 2019
Cooley M&A Insight From Q3 2018
October 25, 2018
Liquidia – $53 Million IPO
August 21, 2018
Best Lawyers 2019 – Cooley
August 16, 2018
Cooley M&A Insight From Q2 2018
August 2, 2018
Scholar Rock – $86 Million IPO
June 18, 2018
ASLAN Pharmaceuticals – $42 Million IPO
June 8, 2018
Chambers USA 2018 Recognizes Cooley Lawyers + Practices
May 3, 2018
DocuSign – $723.7 Million IPO
May 1, 2018
Uber Closes SoftBank Investment
February 12, 2018
ERYTECH – $144 Million IPO
November 22, 2017
Semiconductor Developer Aquantia Closes $71 Million IPO
November 8, 2017
Cooley Advises on Nightstar + NuCana IPOs
October 10, 2017
Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering
September 22, 2017
Zealand Pharma – $89 Million IPO
August 25, 2017
Best Lawyers 2018 – Cooley
August 16, 2017
Ovid – $75 Million IPO
June 13, 2017
Cooley Advises on Series of Life Sciences IPOs
May 30, 2017
Chambers USA 2017 Recognizes Cooley Lawyers + Practices
May 26, 2017
ZIOPHARM Oncology – $50 Million Offering
May 17, 2017
ERYTECH Closes €70.5 Million Private Placement to US + European Investors
May 3, 2017
Yext – $133 Million IPO
April 25, 2017
CytoSorbents – $11.5 Million Shelf Takedown
April 19, 2017
FibroGen – $120 Million Shelf Takedown
Calithera Biosciences – $80 Million Shelf-Takedown Offering
April 7, 2017
Aurinia – $173 Million Offering
March 23, 2017
Prothena – $155 Million Shelf-Takedown Offering
Rigel – $46 Million Shelf-Takedown
February 17, 2017
Mirati – $69 Million Shelf-Takedown
January 12, 2017
Clearlake Capital to Acquire LANDESK and Combine with HEAT Software
NantHealth – $107 Million Notes Offering
January 11, 2017
Aurinia – $28.75 Million Offering
January 6, 2017
Clearside – $36 Million Public Offering
January 3, 2017
ERYTECH Closes €10 Million Private Placement
December 14, 2016
Xencor – $127 Million Shelf-Takedown
December 8, 2016
Ascendis Pharma – $136 Million Follow-On
November 3, 2016
Tabula Rasa – $59 Million IPO
October 25, 2016
Everspin – $40 Million IPO + $5 Million Private Placement
October 18, 2016
Aquinox – $75 Million Public Offering
October 13, 2016
Apptio – $110 Million IPO
October 10, 2016
Catabasis – Underwritten Registered Offering
October 7, 2016
AveXis – $169 Million Follow-On Offering
September 21, 2016
BioMarin – $720 Million Follow-On
September 19, 2016
Sophiris Bio – $30 Million Follow-On
September 13, 2016
Eiger – $20 Million Shelf-Takedown
September 1, 2016
Recro Pharma – $15 Million Follow-On
August 30, 2016
Protagonist Therapeutics – $90 Million IPO
Best Lawyers 2017 – Cooley
August 15, 2016
Selecta Biosciences – $74 Million IPO
July 25, 2016
Minerva – $58 Million Follow-On Offering
July 7, 2016
Flexion – $77 Million Follow-On Offering
Clearside IPO – $50 Million
June 21, 2016
Merus IPO – $61 Million
June 1, 2016
Chambers USA 2016 Recognizes Cooley Lawyers + Practices
May 27, 2016
Oncobiologics – $40 Million IPO and Private Placement
May 19, 2016
Senseonics Holdings, Inc. – $49 Million IPO
April 13, 2016
New Bill Targets Cybersecurity Expertise on Boards of Directors
January 4, 2016
Cooley Advises ERYTECH on €25.4 Million Private Placement
December 9, 2015
Aclaris Therapeutics – IPO
October 20, 2015
Best Lawyers 2016 – Cooley
August 18, 2015
Chambers USA Recognizes 27 Cooley Practice Areas
May 29, 2015
Cooley Advises Jazz Pharmaceuticals plc on Rule 144A Offering of $575 Million of Exchangeable Senior Notes
September 25, 2014
Cooley Advises Underwriters on T2 Biosystems IPO
August 22, 2014
Cooley Advises GlobeImmune on Initial Public Offering
August 7, 2014
Chambers USA Recognizes 25 Leading Cooley Practice Areas
May 23, 2014
Cooley M&A Team News - March 2014
March 27, 2014
Cooley M&A Team News - January 2014
February 5, 2014
Cooley M&A Team News - December 2013
December 17, 2013
Numerous Cooley Attorneys Recognized in Best Lawyers 2014
August 15, 2013
Delaware Chancery Court Upholds Forum Selection Bylaws
July 17, 2013
Cooley Practices and Attorneys Recognized in 2013 Legal 500 Client Guide
June 24, 2013
2013 Chambers USA Recognizes 52 Cooley Attorneys and 22 Practice Areas
June 6, 2013
Cooley Advises Rally on its IPO
April 12, 2013
Cooley Represents Brocade in $300 Million 4.625 % Senior Notes Offering
January 24, 2013
95 Cooley Attorneys Recognized in Best Lawyers
September 19, 2012
2012 Chambers USA Recognizes 52 Cooley Attorneys and 23 Practice Areas
June 11, 2012
Cooley Advises Jazz Pharmaceuticals in Pending Acquisition of EUSA Pharma for up to $700 Million
April 26, 2012
The JOBS Act Relaxes Requirements For Going Public And Being Public
April 5, 2012
Say On Pay Makes its Debut in the 2011 Proxy Season
July 28, 2011
How Would a Federal Government Shutdown Affect the SEC?
April 7, 2011
SEC Proposes New Rules for Compensation Committees and Compensation Consultants
March 31, 2011
SEC Adopts Final Rules on Say on Pay
February 7, 2011
SEC's Proposed Rules on Conflict Minerals Disclosure Could Have Broad Impact
January 13, 2011
Frequency of Say-on-Pay Votes: Eleven Factors to Consider
December 9, 2010
SEC Proposes New Rules for Implementing the Whistleblower Provisions of the Dodd-Frank Act
December 7, 2010
SEC Proposes New Rules for Shareholder Advisory Votes on Executive Compensation
October 28, 2010
SEC Adopts New Rules for Proxy Access
September 16, 2010
The Dodd-Frank Wall Street Reform and Consumer Protection Act: Provisions Related to Corporate Governance and Executive Compensation
July 19, 2010
SEC Publishes Guidance Regarding Disclosure of Climate Change Issues
March 9, 2010
SEC Adopts New Rules for Enhanced Compensation and Corporate Governance Disclosure
January 26, 2010